Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI)

Ashish Sharma, Peter K. Kaiser, Ramin Tadayoni, Frank G. Holz, Luke Nicholson, Clara Vázquez-Alfageme, Sobha Sivaprasad, Taku Wakabayashi, Se Joon Woo, David Sarraf, Nilesh Kumar, Nikulaa Parachuri, Carl D. Regillo, Kourous A. Rezaei, Arshad M. Khanani, Francesco Bandello, Mahesh Shanamugam, Lalit Verma, Mangat Dogra, Muralidhar NS, Manisha Agarwal, Anat Loewenstein, Baruch D. Kuppermann, International Retina Biosimilar Study Group (Inter BIOS Group), Giuseppe Querques, Jay Sheth, Seemantini Ayachit, Chitaranjan Mishra, Debdulal Chakraborty, Alay Banker, Şengül Özdek, Kodjikian Laurent, Alper Bilgic, Paolo Lanzetta, Caroline R. Baumal, Nancy Holekemp, Taiji Sakamoto, Adnan Tufail, Nicolas A. Yannuzzi, Giulia Corradetti, David S. Boyer, Aleksandra Rachitskaya, Tünde Pető, Maximilian W. M. Wintergerst, Valentina Sarao, Barbara Parolini, Prithvi Mruthyunjaya, Quan Dong Nguyen, V. Diana, Pearse A. Keane, T. Hassan, Jayanth Sridhar, David Eichenbaum, Dilraj S. Grewal, Francesc March de Ribot, Martin Splitzer, Martin S. Zinkernagel, Tomoko Ueda‐Consolvo, Masaaki Ishida, Tomoko Nakamura, Shuichiro Yanagisawa, K. Tsuboi, Atsushi Hayashi, Assaf Hilely, Dinah Zur